FDA Import Refusal SCS-6030612-7/41/1 — GENO PHARMACEUTICALS PVT LTD
The FDA refused shipment SCS-6030612-7/41/1 from GENO PHARMACEUTICALS PVT LTD (India) on Sep 27, 2024. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Sep 27, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GDY18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
- Charges
- 75